MRVI · Maravai Lifesciences Holdings, Inc. · Proposed Sales
Market Cap
$1.90B
Shares
259.67M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-10 | ORESHACK KURT | Officer | 25,000 | 2026-06-10 | Fidelity Brokerage Services LLC |
| 2026-06-09 | ORESHACK KURT | Officer | 25,000 | 2026-06-09 | Fidelity Brokerage Services LLC |
| 2025-12-23 | PRAHALAD MURALI | Former Director | 3,951 | 2025-12-23 | Fidelity Brokerage Services LLC |
| 2025-12-19 | Hopfield Jessica | Former Director | 53,951 | 2025-12-19 | Fidelity Brokerage Services LLC |
| 2025-01-31 | ORESHACK KURT | Officer | 25,000 | 2025-01-31 | Fidelity Brokerage Services LLC |
| 2024-05-28 | Maravai Life Sciences Holdings, LLC | Owner | 8,409,946 | 2024-05-28 | Goldman Sachs & Co. LLC |
| 2024-05-28 | Maravai Life Sciences Holdings 2, LLC | Owner | 1,531,028 | 2024-05-28 | Goldman Sachs & Co. LLC |
Showing 1–7 of 7 filings
Key facts
CIK
1823239
CUSIP
56600D107
13F (30d)
128 filings
128 filers
Visit website
Investor relations